nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—Extrinsic Pathway—F3—hematologic cancer	0.0209	0.0977	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—THY1—hematologic cancer	0.0102	0.0477	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CR2—hematologic cancer	0.00952	0.0444	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ITGAD—hematologic cancer	0.00893	0.0417	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGR—hematologic cancer	0.00859	0.0401	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F3—hematologic cancer	0.00764	0.0356	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—LCK—hematologic cancer	0.00658	0.0307	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CR1—hematologic cancer	0.00547	0.0255	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CR2—hematologic cancer	0.00538	0.0251	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ITGAX—hematologic cancer	0.0052	0.0243	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F3—hematologic cancer	0.00514	0.024	CbGpPWpGaD
Fondaparinux sodium—F10—hematopoietic system—hematologic cancer	0.00449	0.314	CbGeAlD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F3—hematologic cancer	0.00431	0.0201	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ITGAL—hematologic cancer	0.00428	0.02	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CR1—hematologic cancer	0.00309	0.0144	CbGpPWpGaD
Fondaparinux sodium—F10—blood—hematologic cancer	0.00297	0.208	CbGeAlD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F3—hematologic cancer	0.00291	0.0136	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGF2—hematologic cancer	0.00277	0.0129	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EHD3—hematologic cancer	0.00265	0.0124	CbGpPWpGaD
Fondaparinux sodium—F10—lung—hematologic cancer	0.00261	0.182	CbGeAlD
Fondaparinux sodium—F10—testis—hematologic cancer	0.00246	0.172	CbGeAlD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—CD40LG—hematologic cancer	0.00229	0.0107	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SPN—hematologic cancer	0.00225	0.0105	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—SRC—hematologic cancer	0.00202	0.00941	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD2—hematologic cancer	0.00201	0.00936	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—hematologic cancer	0.00196	0.00917	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—GCNT4—hematologic cancer	0.00188	0.00877	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—hematologic cancer	0.0018	0.00841	CbGpPWpGaD
Fondaparinux sodium—F10—lymph node—hematologic cancer	0.00178	0.125	CbGeAlD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ICAM1—hematologic cancer	0.00177	0.00826	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—THPO—hematologic cancer	0.00171	0.00796	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD58—hematologic cancer	0.00171	0.00796	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SRGN—hematologic cancer	0.00152	0.0071	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—DPM1—hematologic cancer	0.0015	0.00701	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EHD3—hematologic cancer	0.0015	0.00698	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MPL—hematologic cancer	0.00145	0.00677	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—S100A10—hematologic cancer	0.00139	0.00649	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PREB—hematologic cancer	0.00136	0.00634	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GATA2—hematologic cancer	0.00134	0.00625	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—GCNT1—hematologic cancer	0.0013	0.00608	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SPN—hematologic cancer	0.00127	0.00594	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ATP1B1—hematologic cancer	0.00122	0.00567	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LDHD—hematologic cancer	0.00118	0.00549	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GATA1—hematologic cancer	0.00115	0.00538	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD2—hematologic cancer	0.00113	0.00529	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—MUC1—hematologic cancer	0.00111	0.00517	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ANXA2—hematologic cancer	0.00105	0.00492	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GNA13—hematologic cancer	0.00098	0.00457	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—THPO—hematologic cancer	0.000964	0.0045	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD58—hematologic cancer	0.000964	0.0045	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—JAK3—hematologic cancer	0.000935	0.00436	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGAX—hematologic cancer	0.000935	0.00436	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F3—hematologic cancer	0.000922	0.0043	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD9—hematologic cancer	0.000922	0.0043	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SELL—hematologic cancer	0.000897	0.00418	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GCNT4—hematologic cancer	0.000892	0.00416	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL3RA—hematologic cancer	0.000874	0.00408	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SRGN—hematologic cancer	0.00086	0.00401	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MPL—hematologic cancer	0.00082	0.00383	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—FGR—hematologic cancer	0.000799	0.00373	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—H3F3B—hematologic cancer	0.000799	0.00373	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—S100A10—hematologic cancer	0.000786	0.00367	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—SUMO1—hematologic cancer	0.000781	0.00364	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGAL—hematologic cancer	0.000769	0.00359	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MYB—hematologic cancer	0.000769	0.00359	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CTSZ—hematologic cancer	0.000759	0.00354	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ANPEP—hematologic cancer	0.000759	0.00354	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GATA2—hematologic cancer	0.000757	0.00353	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAC2—hematologic cancer	0.000731	0.00341	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—DPM1—hematologic cancer	0.000713	0.00333	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ASNS—hematologic cancer	0.000713	0.00333	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ATP1B1—hematologic cancer	0.000687	0.00321	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SH2B3—hematologic cancer	0.000662	0.00309	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GATA1—hematologic cancer	0.000651	0.00304	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PREB—hematologic cancer	0.000645	0.00301	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SPARC—hematologic cancer	0.000632	0.00295	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GCNT1—hematologic cancer	0.000618	0.00289	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—LCK—hematologic cancer	0.000612	0.00285	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—H3F3A—hematologic cancer	0.0006	0.0028	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ANXA2—hematologic cancer	0.000596	0.00278	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GATA3—hematologic cancer	0.000594	0.00277	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HSPA5—hematologic cancer	0.000591	0.00276	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCZ—hematologic cancer	0.000583	0.00272	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GNA13—hematologic cancer	0.000554	0.00258	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HDAC2—hematologic cancer	0.000543	0.00253	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGA4—hematologic cancer	0.000537	0.00251	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD44—hematologic cancer	0.000537	0.00251	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—CALR—hematologic cancer	0.000536	0.0025	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—JAK3—hematologic cancer	0.000528	0.00247	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGAX—hematologic cancer	0.000528	0.00247	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MUC1—hematologic cancer	0.000526	0.00245	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL3—hematologic cancer	0.000524	0.00244	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD9—hematologic cancer	0.000521	0.00243	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F3—hematologic cancer	0.000521	0.00243	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA1—hematologic cancer	0.00052	0.00243	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PTPN1—hematologic cancer	0.000515	0.0024	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RASGRP1—hematologic cancer	0.000507	0.00236	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SELL—hematologic cancer	0.000507	0.00236	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SYK—hematologic cancer	0.000505	0.00236	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL3RA—hematologic cancer	0.000494	0.0023	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA2—hematologic cancer	0.000484	0.00226	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPLP1—hematologic cancer	0.00046	0.00214	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GRB2—hematologic cancer	0.000456	0.00213	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PDGFA—hematologic cancer	0.000454	0.00212	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—FGR—hematologic cancer	0.000452	0.00211	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—H3F3B—hematologic cancer	0.000452	0.00211	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ABL1—hematologic cancer	0.000438	0.00204	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGAL—hematologic cancer	0.000435	0.00203	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MYB—hematologic cancer	0.000435	0.00203	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TUBB2A—hematologic cancer	0.000422	0.00197	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAC2—hematologic cancer	0.000413	0.00193	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HGF—hematologic cancer	0.000412	0.00192	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CSF2—hematologic cancer	0.000407	0.0019	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCG—hematologic cancer	0.000393	0.00183	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—JAK1—hematologic cancer	0.000393	0.00183	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MME—hematologic cancer	0.000375	0.00175	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SH2B3—hematologic cancer	0.000374	0.00175	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CMA1—hematologic cancer	0.000371	0.00173	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—SUMO1—hematologic cancer	0.000371	0.00173	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2RA—hematologic cancer	0.000367	0.00171	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—SPHK1—hematologic cancer	0.000363	0.00169	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SPARC—hematologic cancer	0.000357	0.00167	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PDGFB—hematologic cancer	0.000354	0.00165	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—LCK—hematologic cancer	0.000346	0.00161	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CDK2—hematologic cancer	0.000344	0.0016	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—H3F3A—hematologic cancer	0.000339	0.00158	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GATA3—hematologic cancer	0.000336	0.00157	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HSPA5—hematologic cancer	0.000334	0.00156	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK14—hematologic cancer	0.00033	0.00154	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCZ—hematologic cancer	0.000329	0.00154	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS14—hematologic cancer	0.000325	0.00152	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—FN1—hematologic cancer	0.000319	0.00149	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HDAC2—hematologic cancer	0.000307	0.00143	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—hematologic cancer	0.000306	0.00143	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD44—hematologic cancer	0.000303	0.00142	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGA4—hematologic cancer	0.000303	0.00142	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PTPN11—hematologic cancer	0.0003	0.0014	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL3—hematologic cancer	0.000296	0.00138	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNA1—hematologic cancer	0.000294	0.00137	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PTPN1—hematologic cancer	0.000291	0.00136	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RASGRP1—hematologic cancer	0.000286	0.00134	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SYK—hematologic cancer	0.000285	0.00133	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EIF4EBP1—hematologic cancer	0.000284	0.00132	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CREBBP—hematologic cancer	0.000283	0.00132	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNA2—hematologic cancer	0.000274	0.00128	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CD—hematologic cancer	0.000269	0.00125	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—hematologic cancer	0.000265	0.00124	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—HSPA5—hematologic cancer	0.000263	0.00123	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GRB2—hematologic cancer	0.000257	0.0012	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDGFA—hematologic cancer	0.000257	0.0012	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CALR—hematologic cancer	0.000255	0.00119	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3R1—hematologic cancer	0.000254	0.00118	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ABL1—hematologic cancer	0.000247	0.00115	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—JAK2—hematologic cancer	0.000247	0.00115	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—FBXW7—hematologic cancer	0.000246	0.00115	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CB—hematologic cancer	0.000234	0.00109	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HGF—hematologic cancer	0.000233	0.00109	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CSF2—hematologic cancer	0.00023	0.00107	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—JAK1—hematologic cancer	0.000222	0.00104	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCG—hematologic cancer	0.000222	0.00104	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2—hematologic cancer	0.000215	0.001	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL2RA—hematologic cancer	0.000207	0.000967	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDGFB—hematologic cancer	0.0002	0.000934	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CDK2—hematologic cancer	0.000194	0.000906	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EP300—hematologic cancer	0.000193	0.000901	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SRC—hematologic cancer	0.000188	0.000876	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MAPK14—hematologic cancer	0.000186	0.000869	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—hematologic cancer	0.000183	0.000853	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NRAS—hematologic cancer	0.000181	0.000842	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—FN1—hematologic cancer	0.00018	0.000842	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK3—hematologic cancer	0.000173	0.000807	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—hematologic cancer	0.000173	0.000806	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PTPN11—hematologic cancer	0.00017	0.000792	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—hematologic cancer	0.000168	0.000783	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CREBBP—hematologic cancer	0.00016	0.000747	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KRAS—hematologic cancer	0.000155	0.000725	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CD—hematologic cancer	0.000152	0.000708	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—hematologic cancer	0.00015	0.000699	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3R1—hematologic cancer	0.000143	0.000669	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CA—hematologic cancer	0.000143	0.000666	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—JAK2—hematologic cancer	0.000139	0.00065	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—hematologic cancer	0.000138	0.000644	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CB—hematologic cancer	0.000132	0.000617	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HRAS—hematologic cancer	0.000132	0.000616	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CCL2—hematologic cancer	0.000127	0.00059	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL2—hematologic cancer	0.000122	0.000567	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—hematologic cancer	0.000117	0.000544	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EP300—hematologic cancer	0.000109	0.000509	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SRC—hematologic cancer	0.000106	0.000495	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—hematologic cancer	0.000103	0.000482	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NRAS—hematologic cancer	0.000102	0.000476	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MAPK3—hematologic cancer	9.77e-05	0.000456	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB1—hematologic cancer	9.48e-05	0.000442	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KRAS—hematologic cancer	8.78e-05	0.00041	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CA—hematologic cancer	8.07e-05	0.000376	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TP53—hematologic cancer	7.81e-05	0.000364	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HRAS—hematologic cancer	7.46e-05	0.000348	CbGpPWpGaD
Fondaparinux sodium—Body temperature increased—Triamcinolone—hematologic cancer	6.94e-05	9e-05	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—hematologic cancer	6.94e-05	9e-05	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—hematologic cancer	6.94e-05	9e-05	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—hematologic cancer	6.93e-05	8.98e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Betamethasone—hematologic cancer	6.93e-05	8.98e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dexamethasone—hematologic cancer	6.93e-05	8.98e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Mitoxantrone—hematologic cancer	6.91e-05	8.96e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Irinotecan—hematologic cancer	6.91e-05	8.96e-05	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—hematologic cancer	6.9e-05	8.94e-05	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—hematologic cancer	6.89e-05	8.94e-05	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—hematologic cancer	6.88e-05	8.92e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.88e-05	8.92e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.88e-05	8.92e-05	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—hematologic cancer	6.87e-05	8.91e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Betamethasone—hematologic cancer	6.87e-05	8.91e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Dexamethasone—hematologic cancer	6.87e-05	8.91e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—hematologic cancer	6.85e-05	8.88e-05	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—hematologic cancer	6.83e-05	8.85e-05	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—hematologic cancer	6.82e-05	8.85e-05	CcSEcCtD
Fondaparinux sodium—Pain—Dexamethasone—hematologic cancer	6.81e-05	8.83e-05	CcSEcCtD
Fondaparinux sodium—Pain—Betamethasone—hematologic cancer	6.81e-05	8.83e-05	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—hematologic cancer	6.8e-05	8.82e-05	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—hematologic cancer	6.77e-05	8.78e-05	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—hematologic cancer	6.74e-05	8.74e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Gemcitabine—hematologic cancer	6.73e-05	8.73e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Cisplatin—hematologic cancer	6.72e-05	8.71e-05	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—hematologic cancer	6.71e-05	8.7e-05	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—hematologic cancer	6.7e-05	8.68e-05	CcSEcCtD
Fondaparinux sodium—Rash—Cisplatin—hematologic cancer	6.66e-05	8.64e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Cisplatin—hematologic cancer	6.66e-05	8.63e-05	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—hematologic cancer	6.65e-05	8.62e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—hematologic cancer	6.62e-05	8.59e-05	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—hematologic cancer	6.61e-05	8.57e-05	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—AKT1—hematologic cancer	6.59e-05	0.000307	CbGpPWpGaD
Fondaparinux sodium—Anaemia—Methotrexate—hematologic cancer	6.57e-05	8.51e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dexamethasone—hematologic cancer	6.57e-05	8.51e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Betamethasone—hematologic cancer	6.57e-05	8.51e-05	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—hematologic cancer	6.56e-05	8.5e-05	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—hematologic cancer	6.55e-05	8.49e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Betamethasone—hematologic cancer	6.52e-05	8.45e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.52e-05	8.45e-05	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—hematologic cancer	6.51e-05	8.44e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Triamcinolone—hematologic cancer	6.47e-05	8.39e-05	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—hematologic cancer	6.43e-05	8.34e-05	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—hematologic cancer	6.41e-05	8.31e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—hematologic cancer	6.4e-05	8.3e-05	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—hematologic cancer	6.38e-05	8.28e-05	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—hematologic cancer	6.38e-05	8.28e-05	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—hematologic cancer	6.37e-05	8.26e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Dexamethasone—hematologic cancer	6.33e-05	8.21e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Betamethasone—hematologic cancer	6.33e-05	8.21e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisolone—hematologic cancer	6.31e-05	8.19e-05	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—hematologic cancer	6.31e-05	8.19e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Triamcinolone—hematologic cancer	6.3e-05	8.17e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Betamethasone—hematologic cancer	6.3e-05	8.17e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Betamethasone—hematologic cancer	6.3e-05	8.17e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dexamethasone—hematologic cancer	6.3e-05	8.17e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dexamethasone—hematologic cancer	6.3e-05	8.17e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Cisplatin—hematologic cancer	6.28e-05	8.14e-05	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—hematologic cancer	6.28e-05	8.14e-05	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—hematologic cancer	6.27e-05	8.12e-05	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—hematologic cancer	6.23e-05	8.08e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Triamcinolone—hematologic cancer	6.21e-05	8.05e-05	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—hematologic cancer	6.2e-05	8.04e-05	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—hematologic cancer	6.16e-05	7.98e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—hematologic cancer	6.16e-05	7.98e-05	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—hematologic cancer	6.15e-05	7.98e-05	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—hematologic cancer	6.15e-05	7.97e-05	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Prednisone—hematologic cancer	6.11e-05	7.92e-05	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—hematologic cancer	6.1e-05	7.91e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—hematologic cancer	6.1e-05	7.91e-05	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—hematologic cancer	6.06e-05	7.86e-05	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—hematologic cancer	6.06e-05	7.86e-05	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—hematologic cancer	6.05e-05	7.84e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—hematologic cancer	6.03e-05	7.82e-05	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—hematologic cancer	6.02e-05	7.81e-05	CcSEcCtD
Fondaparinux sodium—Rash—Prednisolone—hematologic cancer	6.02e-05	7.81e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisolone—hematologic cancer	6.01e-05	7.8e-05	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.01e-05	7.79e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Prednisone—hematologic cancer	5.98e-05	7.76e-05	CcSEcCtD
Fondaparinux sodium—Headache—Prednisolone—hematologic cancer	5.98e-05	7.76e-05	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—hematologic cancer	5.97e-05	7.74e-05	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—hematologic cancer	5.96e-05	7.73e-05	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—hematologic cancer	5.95e-05	7.72e-05	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—hematologic cancer	5.93e-05	7.69e-05	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—hematologic cancer	5.88e-05	7.62e-05	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—hematologic cancer	5.85e-05	7.58e-05	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—hematologic cancer	5.84e-05	7.58e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Triamcinolone—hematologic cancer	5.81e-05	7.53e-05	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—hematologic cancer	5.8e-05	7.52e-05	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—hematologic cancer	5.8e-05	7.52e-05	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—hematologic cancer	5.8e-05	7.52e-05	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—hematologic cancer	5.76e-05	7.47e-05	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—hematologic cancer	5.76e-05	7.47e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—hematologic cancer	5.75e-05	7.46e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—hematologic cancer	5.72e-05	7.41e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Betamethasone—hematologic cancer	5.72e-05	7.41e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Dexamethasone—hematologic cancer	5.72e-05	7.41e-05	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—hematologic cancer	5.69e-05	7.37e-05	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—hematologic cancer	5.69e-05	7.37e-05	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—hematologic cancer	5.68e-05	7.36e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—hematologic cancer	5.67e-05	7.36e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisolone—hematologic cancer	5.67e-05	7.35e-05	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—hematologic cancer	5.66e-05	7.34e-05	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—hematologic cancer	5.64e-05	7.31e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Dexamethasone—hematologic cancer	5.64e-05	7.31e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Betamethasone—hematologic cancer	5.64e-05	7.31e-05	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—hematologic cancer	5.63e-05	7.3e-05	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.62e-05	7.29e-05	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—hematologic cancer	5.61e-05	7.27e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Triamcinolone—hematologic cancer	5.58e-05	7.24e-05	CcSEcCtD
Fondaparinux sodium—Rash—Triamcinolone—hematologic cancer	5.54e-05	7.18e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Triamcinolone—hematologic cancer	5.53e-05	7.17e-05	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—hematologic cancer	5.53e-05	7.17e-05	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—hematologic cancer	5.53e-05	7.17e-05	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—hematologic cancer	5.52e-05	7.15e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisone—hematologic cancer	5.51e-05	7.15e-05	CcSEcCtD
Fondaparinux sodium—Headache—Triamcinolone—hematologic cancer	5.5e-05	7.13e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—hematologic cancer	5.49e-05	7.11e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—hematologic cancer	5.49e-05	7.11e-05	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—hematologic cancer	5.47e-05	7.09e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dexamethasone—hematologic cancer	5.45e-05	7.07e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Betamethasone—hematologic cancer	5.45e-05	7.07e-05	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—hematologic cancer	5.44e-05	7.05e-05	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—hematologic cancer	5.43e-05	7.04e-05	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—hematologic cancer	5.43e-05	7.04e-05	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—hematologic cancer	5.42e-05	7.02e-05	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—hematologic cancer	5.41e-05	7.01e-05	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—hematologic cancer	5.39e-05	6.99e-05	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—hematologic cancer	5.37e-05	6.96e-05	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—hematologic cancer	5.34e-05	6.92e-05	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—hematologic cancer	5.33e-05	6.91e-05	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—hematologic cancer	5.32e-05	6.9e-05	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—hematologic cancer	5.31e-05	6.89e-05	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—hematologic cancer	5.3e-05	6.87e-05	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—hematologic cancer	5.27e-05	6.83e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Betamethasone—hematologic cancer	5.27e-05	6.83e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Dexamethasone—hematologic cancer	5.27e-05	6.83e-05	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—hematologic cancer	5.25e-05	6.8e-05	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—hematologic cancer	5.24e-05	6.8e-05	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—hematologic cancer	5.24e-05	6.79e-05	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—hematologic cancer	5.22e-05	6.77e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Triamcinolone—hematologic cancer	5.22e-05	6.76e-05	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—hematologic cancer	5.21e-05	6.75e-05	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.2e-05	6.74e-05	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—hematologic cancer	5.17e-05	6.71e-05	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—hematologic cancer	5.17e-05	6.7e-05	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—hematologic cancer	5.16e-05	6.68e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—hematologic cancer	5.11e-05	6.63e-05	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—hematologic cancer	5.1e-05	6.62e-05	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—hematologic cancer	5.07e-05	6.57e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Dexamethasone—hematologic cancer	5.07e-05	6.57e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Betamethasone—hematologic cancer	5.07e-05	6.57e-05	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—hematologic cancer	5.06e-05	6.56e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—hematologic cancer	5.04e-05	6.54e-05	CcSEcCtD
Fondaparinux sodium—Rash—Betamethasone—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Rash—Dexamethasone—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Dexamethasone—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Betamethasone—hematologic cancer	5.02e-05	6.51e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.01e-05	6.49e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—hematologic cancer	5e-05	6.48e-05	CcSEcCtD
Fondaparinux sodium—Headache—Dexamethasone—hematologic cancer	4.99e-05	6.47e-05	CcSEcCtD
Fondaparinux sodium—Headache—Betamethasone—hematologic cancer	4.99e-05	6.47e-05	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—hematologic cancer	4.99e-05	6.47e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—hematologic cancer	4.98e-05	6.45e-05	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—hematologic cancer	4.96e-05	6.43e-05	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—hematologic cancer	4.94e-05	6.4e-05	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—hematologic cancer	4.92e-05	6.38e-05	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—hematologic cancer	4.92e-05	6.37e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—hematologic cancer	4.91e-05	6.36e-05	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—hematologic cancer	4.91e-05	6.36e-05	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—hematologic cancer	4.9e-05	6.35e-05	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—hematologic cancer	4.88e-05	6.32e-05	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—hematologic cancer	4.87e-05	6.32e-05	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—hematologic cancer	4.85e-05	6.29e-05	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—hematologic cancer	4.84e-05	6.27e-05	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—hematologic cancer	4.82e-05	6.25e-05	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—hematologic cancer	4.79e-05	6.21e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—hematologic cancer	4.78e-05	6.2e-05	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—hematologic cancer	4.78e-05	6.19e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—hematologic cancer	4.75e-05	6.15e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—hematologic cancer	4.74e-05	6.15e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Dexamethasone—hematologic cancer	4.73e-05	6.14e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Betamethasone—hematologic cancer	4.73e-05	6.14e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—hematologic cancer	4.72e-05	6.12e-05	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—hematologic cancer	4.69e-05	6.08e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.69e-05	6.07e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—hematologic cancer	4.68e-05	6.07e-05	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—hematologic cancer	4.64e-05	6.02e-05	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—hematologic cancer	4.64e-05	6.02e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—hematologic cancer	4.61e-05	5.97e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisone—hematologic cancer	4.59e-05	5.95e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—hematologic cancer	4.58e-05	5.94e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—hematologic cancer	4.58e-05	5.94e-05	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—hematologic cancer	4.54e-05	5.89e-05	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—hematologic cancer	4.51e-05	5.85e-05	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—hematologic cancer	4.48e-05	5.8e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—hematologic cancer	4.47e-05	5.8e-05	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—hematologic cancer	4.46e-05	5.79e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—hematologic cancer	4.44e-05	5.75e-05	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—hematologic cancer	4.42e-05	5.73e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Prednisone—hematologic cancer	4.41e-05	5.72e-05	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—hematologic cancer	4.37e-05	5.67e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—hematologic cancer	4.37e-05	5.67e-05	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—hematologic cancer	4.36e-05	5.66e-05	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—hematologic cancer	4.35e-05	5.64e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.33e-05	5.62e-05	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—hematologic cancer	4.33e-05	5.61e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—hematologic cancer	4.31e-05	5.59e-05	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—hematologic cancer	4.29e-05	5.57e-05	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—hematologic cancer	4.29e-05	5.57e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—hematologic cancer	4.29e-05	5.56e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—hematologic cancer	4.29e-05	5.56e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—hematologic cancer	4.27e-05	5.54e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—hematologic cancer	4.16e-05	5.39e-05	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—hematologic cancer	4.14e-05	5.36e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—hematologic cancer	4.12e-05	5.34e-05	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.11e-05	5.32e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—hematologic cancer	4.1e-05	5.32e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—hematologic cancer	4e-05	5.18e-05	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—hematologic cancer	3.99e-05	5.17e-05	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—hematologic cancer	3.97e-05	5.15e-05	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—hematologic cancer	3.97e-05	5.15e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—hematologic cancer	3.97e-05	5.14e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—hematologic cancer	3.89e-05	5.05e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—hematologic cancer	3.84e-05	4.98e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—hematologic cancer	3.83e-05	4.97e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—hematologic cancer	3.71e-05	4.81e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—hematologic cancer	3.7e-05	4.8e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—hematologic cancer	3.69e-05	4.78e-05	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—hematologic cancer	3.66e-05	4.74e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—hematologic cancer	3.65e-05	4.74e-05	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—hematologic cancer	3.63e-05	4.71e-05	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—hematologic cancer	3.6e-05	4.67e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—hematologic cancer	3.59e-05	4.65e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—hematologic cancer	3.55e-05	4.61e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—hematologic cancer	3.45e-05	4.47e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—hematologic cancer	3.44e-05	4.47e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—hematologic cancer	3.44e-05	4.45e-05	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—hematologic cancer	3.42e-05	4.44e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—hematologic cancer	3.42e-05	4.43e-05	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—hematologic cancer	3.4e-05	4.41e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—hematologic cancer	3.32e-05	4.3e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—hematologic cancer	3.22e-05	4.18e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—hematologic cancer	3.19e-05	4.14e-05	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—hematologic cancer	3.17e-05	4.1e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—hematologic cancer	3.16e-05	4.1e-05	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—hematologic cancer	3.15e-05	4.08e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—hematologic cancer	2.98e-05	3.87e-05	CcSEcCtD
